Baughman, R.P. (2021) “Roflumilast (Daliresp®) to reduce acute pulmonary events in fibrotic sarcoidosis: a multi-center, double blind, placebo controlled, randomized clinical trial”, Sarcoidosis, Vasculitis and Diffuse Lung Diseases, 38(3), p. e2021035. doi:10.36141/svdld.v38i3.11684.